These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30575147)

  • 1. Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.
    Hernandez AL; Wang Y; Somerset HL; Keysar SB; Aisner DL; Marshall C; Bowles DW; Karam SD; Raben D; Jimeno A; Varella-Garcia M; Wang XJ
    Mol Carcinog; 2019 May; 58(5):666-673. PubMed ID: 30575147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.
    Hernandez AL; Young CD; Bian L; Weigel K; Nolan K; Frederick B; Han G; He G; Devon Trahan G; Rudolph MC; Jones KL; Oweida AJ; Karam SD; Raben D; Wang XJ
    Clin Cancer Res; 2020 Jun; 26(12):3058-3070. PubMed ID: 32139402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased SMAD4 expression is associated with induction of epithelial-to-mesenchymal transition and cetuximab resistance in head and neck squamous cell carcinoma.
    Cheng H; Fertig EJ; Ozawa H; Hatakeyama H; Howard JD; Perez J; Considine M; Thakar M; Ranaweera R; Krigsfeld G; Chung CH
    Cancer Biol Ther; 2015; 16(8):1252-8. PubMed ID: 26046389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells.
    Ozawa H; Ranaweera RS; Izumchenko E; Makarev E; Zhavoronkov A; Fertig EJ; Howard JD; Markovic A; Bedi A; Ravi R; Perez J; Le QT; Kong CS; Jordan RC; Wang H; Kang H; Quon H; Sidransky D; Chung CH
    Clin Cancer Res; 2017 Sep; 23(17):5162-5175. PubMed ID: 28522603
    [No Abstract]   [Full Text] [Related]  

  • 5. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation.
    Bornstein S; White R; Malkoski S; Oka M; Han G; Cleaver T; Reh D; Andersen P; Gross N; Olson S; Deng C; Lu SL; Wang XJ
    J Clin Invest; 2009 Nov; 119(11):3408-19. PubMed ID: 19841536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.
    Peng S; Creighton CJ; Zhang Y; Sen B; Mazumdar T; Myers JN; Lai SY; Woolfson A; Lorenzi MV; Bell D; Williams MD; Johnson FM
    J Transl Med; 2013 Aug; 11():198. PubMed ID: 23981300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression.
    Huang Q; Yu GP; McCormick SA; Mo J; Datta B; Mahimkar M; Lazarus P; Schäffer AA; Desper R; Schantz SP
    Genes Chromosomes Cancer; 2002 Jun; 34(2):224-33. PubMed ID: 11979556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-target fluorescence in situ hybridization distinguishes multiple genetically aberrant clones in head and neck squamous cell carcinoma.
    Veltman JA; Hopman AH; van der Vlies SA; Bot FJ; Ramaekers FC; Manni JJ
    Cytometry; 1998 Jun; 34(3):113-20. PubMed ID: 9696155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
    Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
    Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
    Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA
    Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct nonrandom patterns of chromosomal aberrations in the progression of squamous cell carcinomas of the head and neck.
    Soder AI; Hopman AH; Ramaekers FC; Conradt C; Bosch FX
    Cancer Res; 1995 Nov; 55(21):5030-7. PubMed ID: 7585547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations.
    Wemmert S; Linxweiler M; Lerner C; Bochen F; Kulas P; Linxweiler J; Smola S; Urbschat S; Wagenpfeil S; Schick B
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1129-1141. PubMed ID: 29560516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic analysis of primary head and neck squamous carcinoma by combined fluorescence in situ hybridization and DNA flow cytometry.
    el-Naggar AK; Dinh M; Tucker S; Luna MA; Goepfert H; Hsu P; Batsakis JG
    Am J Clin Pathol; 1996 Jan; 105(1):102-8. PubMed ID: 8561074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH; Ely K; McGavran L; Varella-Garcia M; Parker J; Parker N; Jarrett C; Carter J; Murphy BA; Netterville J; Burkey BB; Sinard R; Cmelak A; Levy S; Yarbrough WG; Slebos RJ; Hirsch FR
    J Clin Oncol; 2006 Sep; 24(25):4170-6. PubMed ID: 16943533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of numerical chromosomal aberrations by FISH in "DNA-diploid" head and neck squamous cell carcinomas].
    Nakai S; Katsura K; Sugihara H; Fujita S
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():149-52. PubMed ID: 7611779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
    Qiu W; Schönleben F; Li X; Su GH
    Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad4: gatekeeper gene in head and neck squamous cell carcinoma.
    Korc M
    J Clin Invest; 2009 Nov; 119(11):3208-11. PubMed ID: 19841540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma.
    Bockmühl U; Schlüns K; Schmidt S; Matthias S; Petersen I
    Genes Chromosomes Cancer; 2002 Jan; 33(1):29-35. PubMed ID: 11746985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.